转化生长因子β/骨形成蛋白通路与肺动脉高压遗传学机制的研究进展 |
| |
引用本文: | 陈娟.转化生长因子β/骨形成蛋白通路与肺动脉高压遗传学机制的研究进展[J].国际儿科学杂志,2016(8):593-597. |
| |
作者姓名: | 陈娟 |
| |
作者单位: | 200062,上海交通大学附属儿童医院上海市儿童医院心脏内科 |
| |
基金项目: | 上海市科委自然基金项目(14ZR1434300)Natural Foundation of Shanghai Science and Technology Commission(14ZR1434300) |
| |
摘 要: | 肺动脉高压由多种心、肺疾病所致,以动脉压力进行性升高、肺血管阻力逐渐增加为特征,最终导致右心衰竭和死亡,其发病机制至今尚未完全阐明.近期有研究发现,转化生长因子β/骨形成蛋白通路对肺动脉高压的发生发展可产生重要影响.针对转化生长因子β/骨形成蛋白通路的研究为肺动脉高压的防治提供了新的理论依据.该文就转化生长因子β/骨形成蛋白通路与肺动脉高压遗传学机制作一综述.
|
关 键 词: | 肺动脉高压 转化生长因子β 骨形成蛋白 Smad 丝裂原活化蛋白激酶 |
Progress of transforming growth factor beta/bone morphogenetic protein pathway and genetic mechanisms of pulmonary arterial hypertension |
| |
Abstract: | Pulmonary arterial hypertension is the result of a variety of heart,lung disease and finally leads to right heart failure and death.Pulmonary arterial hypertension is characterized by the progressive increasing of artery pressure and the gradually increasing of pulmonary vascular resistance,and its pathogenesis has not been fully elucidated.Recent studies have found that transforming growth factor beta/bone morphogenetic protein pathway plays an important role in pulmonary arterial hypertension.The research about transforming growth factor betal bone morphagenetic protein pathway provides a new theoretical basis for the prevention and treatment of pulmonary arterial hypertension.This review focuses on progress of transforming growth factor beta/bone morphogenetic protein pathway and genetic mechanisms of pulmonary arterial hypertension. |
| |
Keywords: | Pulmonary artery hypertension Transforming growth factor beta Bone morphogenetic protein Smad Mitogen activated protein kinase |
本文献已被 万方数据 等数据库收录! |